Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Healthy Extracts ( (HYEX) ) has issued an update.
Healthy Extracts announced the acquisition of Gummy USA LLC on July 19, 2025, through a Membership Interest Purchase Agreement, making Gummy USA a wholly-owned subsidiary. The acquisition involved issuing 13,075,920 shares of common stock to Donald Swanson, who was also appointed to several leadership roles. However, on September 26, 2025, the acquisition was rescinded, and a merger agreement was reached on September 30, 2025, re-establishing Gummy USA as a subsidiary and re-appointing Swanson to leadership positions. This strategic move is expected to enhance Healthy Extracts’ market position by leveraging Swanson’s expertise in gummy innovation and pharmaceutical-grade manufacturing.
Spark’s Take on HYEX Stock
According to Spark, TipRanks’ AI Analyst, HYEX is a Neutral.
Healthy Extracts’ stock reflects a moderate score driven primarily by its financial performance and technical analysis. While the company shows revenue growth potential, persistent profitability challenges and high leverage are significant risks. The stock’s technical indicators suggest a bullish trend, but overbought conditions warrant caution. The negative P/E ratio and lack of dividends further impact the overall score.
To see Spark’s full report on HYEX stock, click here.
More about Healthy Extracts
Average Trading Volume: 1,389
Technical Sentiment Signal: Strong Sell
Current Market Cap: $21.93M
See more insights into HYEX stock on TipRanks’ Stock Analysis page.